[Federal Register Volume 84, Number 173 (Friday, September 6, 2019)]
[Notices]
[Pages 46958-46959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19260]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Heritable Disorders in 
Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Heritable Disorders in 
Newborns and Children (ACHDNC) has scheduled a public meeting. 
Information about ACHDNC and the agenda for this meeting can be found 
on the ACHDNC website at: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html.

DATES: September 24, 2019, 10:00 a.m.-1:00 p.m. Eastern Time (ET).

ADDRESSES: This meeting will be held via webinar. While this meeting is 
open to the public, advance registration is required. Please visit the 
ACHDNC website for information on registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. The deadline for 
online registration is 12:00 p.m. ET on September 23, 2019. 
Instructions on how to access the meeting via webcast will be provided 
upon registration.

FOR FURTHER INFORMATION CONTACT: Alaina Harris, Maternal and Child 
Health Bureau (MCHB), HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; 301-443-0721; or [email protected].

SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations 
to the Secretary of HHS (Secretary) on the development of newborn 
screening activities, technologies, policies, guidelines, and programs 
for effectively reducing morbidity and mortality in newborns and 
children having, or at risk for, heritable disorders. ACHDNC's 
recommendations regarding inclusion of additional conditions for 
screening, following adoption by the Secretary, are evidence-informed 
preventive health services provided for in the comprehensive guidelines 
supported by HRSA through the Recommended Uniform Screening Panel 
(RUSP) pursuant to section 2713 of the Public Health Service Act (42 
U.S.C. 300gg-13). Under this provision, non-grandfathered group health 
plans and health insurance issuers offering group or individual health 
insurance are required to provide insurance coverage without cost-
sharing (a co-payment, co-insurance, or deductible) for preventive

[[Page 46959]]

services for plan years (i.e., policy years) beginning on or after the 
date that is one year from the Secretary's adoption of the condition 
for screening.
    During the September meeting, ACHDNC will hear from experts in the 
fields of public health, medicine, heritable disorders, rare disorders, 
and newborn screening. Agenda items include a discussion of the role of 
health information technology within state newborn screening programs 
and general updates on ACHDNC projects focused on newborn screening. 
Agenda items are subject to changes as priorities dictate and the final 
meeting agenda will be available on ACHDNC's website: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. 
Information about the ACHDNC, a roster of members, as well as past 
meeting summaries are also available on the ACHDNC website.
    Members of the public will have the opportunity to provide 
comments. Requests to offer oral comments will be accepted in the order 
they are requested and may be limited as time allows. Public 
participants may also submit written statements. To submit written 
comments or request time for an oral comment at the meeting, please 
register online by 12:00 p.m. ET on September 19, 2019. Visit the 
ACHDNC website for information on registration, https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. Oral comments will 
be honored in the order they are requested and may be limited as time 
allows. Individuals associated with groups or who plan to provide 
comments on similar topics may be asked to combine their comments and 
present them through a single representative. No audiovisual 
presentations are permitted. Written comments should identify the 
individual's name, address, email, telephone number, professional or 
organization affiliation, background or area of expertise (i.e., 
parent, family member, researcher, clinician, public health, etc.) and 
the topic/subject matter.

Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-19260 Filed 9-5-19; 8:45 am]
BILLING CODE 4165-15-P